EUVIMEDEUVIMED entdecken
Crossref

Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series

Neil Vaishampayan iD, Justin Jee iD, Jamie Chaft iD, Kathryn Arbour iD, Mark Kris, Gregory Riely iD, Rachel Rosenblum, Andrew Plodkowski iD, Helena Yu iD

JCO Precision Oncology · 2026-11 · 10 (11)

DOI: 10.1200/po-26-00679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-11. Verfasst von Neil Vaishampayan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medical College, New York, NY. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medicine, Weill Cornell Medical College, New York, NY.
  • Department of Medicine, Sloan Kettering Cancer Center, New York, NY.
  • Department of Radiology, Sloan Kettering Cancer Center, New York, NY.

ORCID-Profile: Neil Vaishampayan, Justin Jee, Jamie Chaft, Kathryn Arbour, Gregory Riely, Andrew Plodkowski, Helena Yu

Zitieren

APA

Vaishampayan, N., Jee, J., Chaft, J., Arbour, K., Kris, M., Riely, G., Rosenblum, R., Plodkowski, A., & Yu, H. (2026). Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series. JCO Precision Oncology, 10(11). https://doi.org/10.1200/po-26-00679

Vancouver

Vaishampayan N, Jee J, Chaft J, Arbour K, Kris M, Riely G, et al. Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series. JCO Precision Oncology. 2026;10(11). doi:10.1200/po-26-00679

BibTeX
@article{Vaishampayan2026,
  author = {Vaishampayan, Neil and Jee, Justin and Chaft, Jamie and Arbour, Kathryn and Kris, Mark and Riely, Gregory and Rosenblum, Rachel and Plodkowski, Andrew and Yu, Helena},
  title = {Osimertinib Toxicity Prompting Lazertinib Monotherapy: A Case Series},
  journal = {JCO Precision Oncology},
  year = {2026},
  volume = {10},
  number = {11},
  doi = {10.1200/po-26-00679}
}
Kostenlos starten →